Eva Wirkert

Sensory contact to the stressor prevents recovery from structural and functional heart damage following psychosocial trauma

H. Gündel, J. Fegert, M. Frick, 2019, Brain, Behavior, and Immunity.

Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis

Adam R Ferguson, U. Bogdahn, G. Schuierer, 2021, Journal of the Neurological Sciences.

Safe and Effective Cynomolgus Monkey GLP—Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders

U. Bogdahn, L. Aigner, L. Mecklenburg, 2022, Pharmaceutics.

Direct Potential Modulation of Neurogenic Differentiation Markers by Granulocyte-Colony Stimulating Factor (G-CSF) in the Rodent Brain

U. Bogdahn, L. Aigner, Eva Wirkert, 2022, Pharmaceutics.

Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2—A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling

U. Bogdahn, L. Aigner, Eva Wirkert, 2020, International journal of molecular sciences.

Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling

U. Bogdahn, S. Petri, L. Aigner, 2021, Neurotherapeutics.

Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients

U. Bogdahn, B. Budeus, W. Herr, 2018, Front. Neurol..